PROSTINE E2 2 mg/3 g, vaginal gel syringe, 3 g
Active ingredients: Prostaglandin E2
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Gelsyringe, 3 gvaginale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- PROSTINE E2 2 mg/3 g, gel vaginal
- Pharmaceutical form
- gel
- Route of administration
- vaginale
- Presentation description
- 1 seringue(s) pré-remplie(s) polyéthylène de 3 g
- Marketing authorisation holder
- PFIZER HOLDING FRANCE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Jun 1993
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Hospital use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63145144CIP75577508CIP133400955775089Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| DINOPROSTONEgel | 2 mg · une seringue pré-remplie | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.